Drug class
Synthetic polypeptide immunomodulator; multiple sclerosis disease-modifying therapy
Mechanism of action
The mechanisms of action are not fully understood. Glatiramer acetate is thought to modulate immune responses, including effects on antigen-presenting cells and T-cell populations, shifting responses toward anti-inflammatory phenotypes and potentially reducing CNS-directed inflammatory activity.
General use cases
- Treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease, under the applicable product label
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
